Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AquaThirst is a biotechnology company focused on the development and commercialization of therapeutic solutions for xerostomia, commonly known as dry mouth. Founded on research from the University of Pennsylvania, the company developed a proprietary mucoadhesive delivery system designed to provide sustained oral hydration and relief for patients with salivary gland dysfunction. Its primary product offerings included long-lasting moisturizing discs and specialized formulations for individuals suffering from Sjögren's syndrome or radiation-induced dry mouth. Although the company established early manufacturing and licensing partnerships, it has largely transitioned out of active operations in recent years.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AquaThirst.